FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Arthur Weaver

Research Profile

Chemicals & Drugs

Disorders

Procedures

Double-Blind Method

Concepts & Ideas

Co-author Network

Publications

TOP 3
Arthur L Weaver
Current and emerging treatments for mild/moderate acute ambulatory pain.
Arthur L Weaver; Michelle A Cheh; Richard H Kennison
How PCP education can impact gout management: the gout essentials.
Arthur L Weaver
Introduction: professionals in dialogue: sharing insights and knowledge into gout management.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Arthur Weaver (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Arthur L Weaver
Current and emerging treatments for mild/moderate acute ambulatory pain.
American journal of therapeutics 2008;15 Suppl 10():S12-6.
2008: Arthur L Weaver; Michelle A Cheh; Richard H Kennison
How PCP education can impact gout management: the gout essentials.
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2008;14(5 Suppl):S42-6.
2008: Arthur L Weaver
Introduction: professionals in dialogue: sharing insights and knowledge into gout management.
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2008;14(5 Suppl):S41.
2008: Arthur L Weaver
Epidemiology of gout.
Cleveland Clinic journal of medicine 2008;75 Suppl 5():S9-12.
2008: Stanley B Cohen; Marc D Cohen; John J Cush; Roy Fleischmann; Philip J Mease; Michael H Schiff; Lee S Simon; Arthur L Weaver
Unresolved issues in identifying and overcoming inadequate response in rheumatoid arthritis: weighing the evidence.
The Journal of rheumatology. Supplement 2008;81():4-30; quiz 31-4.
2006: Arthur L Weaver
Case 3: acute gout-risk factors and inappropriate therapy.
The American journal of medicine 2006;119(11 Suppl 1):S9-12.
2006: Arthur L Weaver
Case 1: differential diagnosis of an acute gouty attack.
The American journal of medicine 2006;119(11 Suppl 1):S2-3.
2006: Steven S Smugar; Thomas J Schnitzer; Arthur L Weaver; Bernard R Rubin; Adam B Polis; Andrew M Tershakovec
Rofecoxib 12.5 mg, rofecoxib 25 mg, and celecoxib 200 mg in the treatment of symptomatic osteoarthritis: results of two similarly designed studies.
Current medical research and opinion 2006;22(7):1353-67.
2006: Arthur L Weaver; Ronald P Messner; William W Storms; Adam B Polis; Daryl K Najarian; Richard A Petruschke; Gregory P Geba; Andrew M Tershakovec
Treatment of patients with osteoarthritis with rofecoxib compared with nabumetone.
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2006;12(1):17-25.
2006: Arthur L Weaver; Richard L Lautzenheiser; Michael H Schiff; Allan Gibofsky; James L Perruquet; John Luetkemeyer; Harold E Paulus; H Amy Xia; Jonathan A Leff
Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry.
Current medical research and opinion 2006;22(1):185-98.
2005: Thomas J Schnitzer; Arthur L Weaver; Adam B Polis; Richard A Petruschke; Gregory P Geba
Efficacy of rofecoxib, celecoxib, and acetaminophen in patients with osteoarthritis of the knee. A combined analysis of the VACT studies.
The Journal of rheumatology 2005;32(6):1093-105.
2004: Wendy P Battisti; Nathaniel P Katz; Arthur L Weaver; Alan K. Matsumoto; Alan J Kivitz; Adam B Polis; Gregory P Geba
Pain management in osteoarthritis: a focus on onset of efficacy--a comparison of rofecoxib, celecoxib, acetaminophen, and nabumetone across four clinical trials.
The journal of pain : official journal of the American Pain Society 2004;5(9):511-20.
2004: Arthur L Weaver
The impact of new biologicals in the treatment of rheumatoid arthritis.
Rheumatology (Oxford, England) 2004;43 Suppl 3():iii17-iii23.
2004: Arthur L Weaver
Efficacy and safety of the anti-TNF biologic agents.
Modern rheumatology / the Japan Rheumatism Association 2004;14(2):101-12.
2003: Ted R Mikuls; Arthur L Weaver
Lessons learned in the use of tumor necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis.
Current rheumatology reports 2003;5(4):270-7.
2003: Roy Fleischmann; Scott W Baumgartner; Elizabeth Tindall; Arthur L Weaver; Larry W Moreland; Michael H Schiff; Richard W Martin; George Spencer-Green
Response to etanercept (Enbrel) in elderly patients with rheumatoid arthritis: a retrospective analysis of clinical trial results.
The Journal of rheumatology 2003;30(4):691-6.
2002: Mark C Genovese; Joan M Bathon; Richard W Martin; Roy Fleischmann; John Tesser; Michael H Schiff; Edward C Keystone; Mary Chester Wasko; Larry W Moreland; Arthur L Weaver; Joseph A Markenson; Grant W Cannon; George Spencer-Green; barbara finck
Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes.
Arthritis and rheumatism 2002;46(6):1443-50.
2002: Gregory P Geba; Arthur L Weaver; Adam B Polis; Mary E Dixon; Thomas J Schnitzer
Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomized trial.
JAMA : the journal of the American Medical Association 2002;287(1):64-71.
2000: Joan M Bathon; R W Martin; Roy Fleischmann; John Tesser; Michael H Schiff; E C Keystone; Mark C Genovese; Mary Chester Wasko; Larry W Moreland; Arthur L Weaver; Joseph A Markenson; barbara finck
A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis.
The New England journal of medicine 2000;343(22):1586-93.
1999: N M Agrawal; J Caldwell; A J Kivitz; Arthur L Weaver; T S Bocanegra; J Ball; S Dhadda; S Hurley; L Hancock
Comparison of the upper gastrointestinal safety of Arthrotec 75 and nabumetone in osteoarthritis patients at high risk for developing nonsteroidal anti-inflammatory drug-induced gastrointestinal ulcers.
Clinical therapeutics 1999;21(4):659-74.
1999: Larry W Moreland; Michael H Schiff; Scott W Baumgartner; Elizabeth Tindall; Roy Fleischmann; Ken J Bulpitt; Arthur L Weaver; Edward C Keystone; Daniel E Furst; P J Mease; Eric M Ruderman; David A Horwitz; Daniel G Arkfeld; L Garrison; Daniel J Burge; CM Blosch; M L Lange; N D McDonnell; Michael E Weinblatt
Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.
Annals of internal medicine 1999;130(6):478-86.
1997: Larry W Moreland; Scott W Baumgartner; Michael H Schiff; Elizabeth Tindall; Roy Fleischmann; Arthur L Weaver; Robert Ettlinger; S Cohen; W J Koopman; K Mohler; M B Widmer; CM Blosch
Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein.
The New England journal of medicine 1997;337(3):141-7.
1995: Jeffrey B Raskin; Richard H White; J E Jackson; Arthur L Weaver; Elizabeth Tindall; R B Lies; D S Stanton
Misoprostol dosage in the prevention of nonsteroidal anti-inflammatory drug-induced gastric and duodenal ulcers: a comparison of three regimens.
Annals of internal medicine 1995;123(5):344-50.